醫藥生物技術領域聯合推廣行銷（2014-2024）

本報告深入了解並分析了公司如何以及為何進行聯合促銷和聯合行銷交易。

這份經過全面修訂的報告提供了2014年至2024年聯合促銷和聯合行銷交易的詳細資訊。

本報告提供了雙方宣布的聯合促銷和聯合行銷協議的付款條款。這些資料提供了有關支付條款和其他交易條款的有用見解。

了解潛在合作夥伴談判條款和條件的靈活性以及條款談判期間的預期內容可以為談判過程提供重要的見解。許多小型企業會要求提供有關付款條件的詳細信息，但在觸發付款以及如何轉讓權利時，細節是關鍵。

本報告提供了當前協議交易和合作夥伴資料庫中記錄的自2014年以來宣布的聯合促銷和聯合營銷交易的完整列表，以及可用的財務條款，以及提供的線上鏈接合作夥伴向美國證券交易委員會提交的實際聯合推廣/聯合行銷協議文件的副本。

主要優點

本報告為讀者提供了以下主要好處：

• 了解2014年以來的交易完成趨勢
• 查看聯合促銷和聯合行銷交易
• 基準分析：確定交易的市場價值
• 財務狀況
• 交易清單：依公司名稱（A-Z）、依治療領域、依技術類型
• 主要交易（金額基礎）
• 最活躍的交易撮合者
• 每筆交易的資產識別和交易條件
• 取得合約文件：深入了解交易結構
• 實質審查：評估擬議交易條款對合作夥伴公司的適用性
• 節省數百小時的研究時間

調查範圍

• 本報告目的是詳細了解全球領先的生物製藥公司之間的共同推廣和聯合行銷趨勢以及交易結構。

此報告中的交易包括：

• 生物製藥產業聯合促銷與聯合行銷交易的趨勢
• 聯合促銷/聯合行銷交易架構：概述
• 製藥和生物技術行業的聯合促銷和聯合行銷交易記錄列表
• 主要聯合促銷與聯合行銷交易（價值基礎）
• 最活躍的共同促銷/聯合行銷交易促成者
• 共同推廣與共同行銷的主要合作夥伴資源

此報告列出了可獲得資訊的交易：

• 依公司名稱（A-Z）
• 按交易金額
• 依治療領域
• 依技術型
• 每個交易標題都透過網路連結連結到實際交易記錄的線上版本。
• 此報告提供了對許可協議的可用合約文件的全面存取。

透過分析合約協議，實質審查可以：

• 授予和選擇了哪些權利？
• 合約授予了哪些權利？
• 授予哪些專有權？
• 合約的付款結構是怎樣的？
• 如何審核銷售和付款？
• 合約期限是多久？
• 合約的主要條款是如何定義的？
• 如何對待和擁有知識產權？
• 誰負責商業化？
• 誰負責開發、供應和製造？
• 如何管理保密和發布？
• 如何解決爭議？
• 什麼情況下可以取消合約？
• 如果所有者發生變化會怎樣？
• 已就何種類型的分授權或分包條款達成協議？
• 公司需要哪些樣板條款？
• 哪些樣板條款會根據合作夥伴和交易類型的不同而有所不同？
• 每家公司都主張合約法中的哪一個管轄權？

目錄

執行摘要

第1章 簡介

第2章 聯合促銷與聯合行銷交易趨勢

• 簡介
• 聯合促銷/聯合行銷協議的定義
• 聯合促銷和聯合行銷協議的趨勢（自2014年以來）
  • 達成聯合促銷/行銷交易：依年份（2014-2024年）
  • 達成聯合促銷/行銷交易：依發展階段：依2014-2024年）
  • 達成聯合促銷/行銷交易：依行業分類（2014-2024年）
  • 達成聯合促銷/行銷交易：依治療領域：依2014-2024年）
  • 達成聯合促銷/行銷交易：依技術類型：依2014-2024年）
  • 達成聯合促銷/行銷交易：針對最活躍的公司（2014-2024年）
• 簽訂聯合促銷/聯合行銷協議的原因
• 未來聯合促銷/聯合行銷協議

第3章 聯合促銷與聯合行銷交易架構：概述

• 簡介
• 聯合促銷/聯合行銷協議的架構

第4章 重大聯合促銷及聯合行銷交易

• 簡介
• 主要聯合促銷與聯合行銷交易（價值基礎）

第5章 最活躍的聯合促銷/聯合行銷交易撮合者前 25 名

• 簡介
• 前 25 位最活躍的聯合促銷/聯合行銷交易撮合者

第6章 聯合促銷/聯合行銷協議清單（包括合約細節）

• 簡介
• 聯合促銷與聯合行銷交易協議（2014-2024年）
• 交易列表
• 交易清單：聯合促銷/聯合行銷協議，依公司名稱（A-Z）
• 交易清單：聯合促銷/聯合行銷協議，依治療領域
• 交易清單：聯合促銷/聯合行銷協議，依技術類型
• 關於Biopharma Research Ltd
• 目前的合作關係
• 當前合約
• 最近發布的Current Partnering報告標題

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals.

Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2014 to 2024.

The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.

Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2014 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.

The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2014. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.

Key benefits

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2014
• Browse co-promotion and co-marketing deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:

• Trends in co-promotion and co-marketing dealmaking in the biopharma industry
• Overview of co-promotion and co-marketing deal structure
• Directory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnology
• The leading co-promotion and co-marketing deals by value
• Most active co-promotion and co-marketing dealmakers
• The leading co-promotion and co-marketing partnering resources

In Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-promotion and co-marketing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2014
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2014-2024
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2014-2024
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2014-2024
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2014-2024
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2014-2024
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2014-2024
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2014-2024
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2014-2024
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2014-2024
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2014-2024
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2014-2024
• Figure 6: Co-promotion and co-marketing deals by technology type, 2014-2024
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2014-2024
• Figure 8: Top co-promotion and co-marketing deals by value, 2014-2024
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2014-2024